Resolution on the results of Advisory Board “Searching the effective methods of testing and treating patients with NSCLC caused by <i>NTRK</i> gene fusions“

The Advisory Board was held on December 24, 2021. The molecular genetic research lead specialists and national lead oncologists discussed issues of diagnosis of NTRK gene translocations in patients with non-small cell lung cancer (NSCLC), as well as current opportunities for the treatment of patient...

Descrizione completa

Dettagli Bibliografici

Autori principali:	E. V. Artamonova, V. V. Breder, L. Yu. Vladimirova, I. A. Demidova, E. N. Imyanitov, К. К. Laktionov, M. P. Matrosova, S. V. Orlov, E. О. Rodionov, D. D. Sakaeva, M. I. Sekacheva, A. V. Smolin, N. V. Fadeeva, M. L. Filipenko
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	Remedium Group LLC 2022-06-01
Serie:	Медицинский совет
Soggetti:	<i>ntrk</i> gene fusions larotrectinib ngs (next generation sequencing) trk inhibitors non-small cell lung cancer
Accesso online:	https://www.med-sovet.pro/jour/article/view/6916
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!